Can Fite Biopharma Stock Analysis
| CANF Stock | USD 1.03 0.01 0.98% |
Can Fite Biopharma is fairly valued with Real Value of 1.02 and Hype Value of 1.03. The main objective of Can Fite stock analysis is to determine its intrinsic value, which is an estimate of what Can Fite Biopharma is worth, separate from its market price. There are two main types of Can Fite's stock analysis: fundamental analysis and technical analysis.
The Can Fite stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Can Fite's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Can Fite Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Can Stock Analysis Notes
The book value of the company was currently reported as 0.0. The company last dividend was issued on the 10th of May 2019. Can Fite Biopharma had 1:10 split on the 9th of January 2023. Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah Tikva, Israel. Can-Fite Biopharma operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 8 people. For more info on Can Fite Biopharma please contact Pnina Fishman at 972 3 924 1114 or go to https://www.canfite.com.Can Fite Biopharma Investment Alerts
| Can Fite Biopharma generated a negative expected return over the last 90 days | |
| Can Fite Biopharma has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 674 K. Net Loss for the year was (7.88 M) with profit before overhead, payroll, taxes, and interest of 674 K. | |
| Can Fite Biopharma currently holds about 12.77 M in cash with (7.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47. |
Can Fite Biopharma Upcoming and Recent Events
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 6th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Can Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.79 M.Technical Drivers
As of the 23rd of July, Can Fite shows the Mean Deviation of 1.63, risk adjusted performance of (0.06), and Standard Deviation of 2.51. Can Fite Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Can Fite Biopharma variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Can Fite Biopharma is priced correctly, providing market reflects its regular price of 1.03 per share. Given that Can Fite is a hitting penny stock territory we recommend to closely look at its jensen alpha.Can Fite Biopharma Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Can Fite middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Can Fite Biopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Can Fite Outstanding Bonds
Can Fite issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Can Fite Biopharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Can bonds can be classified according to their maturity, which is the date when Can Fite Biopharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Can Fite Predictive Daily Indicators
Can Fite intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Can Fite stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 2923.23 | |||
| Daily Balance Of Power | 0.3333 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.04 | |||
| Day Typical Price | 1.03 | |||
| Period Momentum Indicator | 0.01 | |||
| Relative Strength Index | 44.36 |
Can Fite Forecast Models
Can Fite's time-series forecasting models are one of many Can Fite's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Can Fite's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Can Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Can Fite prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Can shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Can Fite. By using and applying Can Stock analysis, traders can create a robust methodology for identifying Can entry and exit points for their positions.
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah Tikva, Israel. Can-Fite Biopharma operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 8 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Can Fite to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Complementary Tools for Can Stock analysis
When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |